is dedicated to providing, developing and producing high-performance advanced medical imaging, radiotherapy equipment, life science instruments and offers intelligent digital solutions to customers worldwide. UIH is committed to creating more value for our customers and constantly improving the global accessibility of high-end medical equipment and services through in-depth cooperation with hospitals, universities, research institutions, and industry partners.

Perceptive is a globally leading technology-enabled service provider, specializing in delivering preclinical and clinical trial imaging, IRT/RTSM (Interactive Response Technology/Randomization and Trial Supply Management) services for drug developers and the global clinical research community. Leveraging industry-leading service levels, profound scientific expertise, and robust technological capabilities, Perceptive empowers pharmaceutical and biotechnology companies worldwide to accelerate and optimize clinical trial outcomes, driving life-saving therapies to reach millions of patients faster. With operations spanning the United States, Europe, the UK, and Asia, the company provides around-the-clock support to premier global pharmaceutical and biotech firms.

 Founded in 2011, Quarkmed is a professional clinical CRO service company. Its headquarters is located in Beijing, and it has established branches and offices in regions such as Shanghai, Guangzhou, Hangzhou, Chengdu, Wuhan, Zhengzhou, and Shenyang. Its business covers comprehensive clinical research service segments including biological testing, clinical research of innovative drugs, clinical research of generic drugs, data statistics, etc. Moreover, it can provide international registration services, covering regions such as Europe, Australia, and North America. Quarkmed keeps exploring the integration of artificial intelligence and clinical research, and continuously deepens the digital transformation of clinical management.

Founded in 2017, GoBroad Healthcare Group focuses on clinical treatment, clinical research, reference laboratories and information technology. GHG has joined hands with a group of top-notch medical experts with rich clinical experience and scientific research backgrounds to create a unique “Academic Research Organization (ARO)”. Our organizational strategy is to build an innovative medical ecosystem of “clinical discovery-basic research-industrial transformation-clinical application” and improve the efficiency and quality of development in the biomedicine industry.

Grand Pharmaceutical Group Co., Ltd. (stock code: 00512. HK) is a research-based international pharmaceutical enterprise that specialises in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology and biotechnology.